QuantHealth
PrivateLast Round
Series B
Aug 4, 2026
Est. Valuation
$27.27M
Total Funding Raised
$75M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
QuantHealth operates in Healthcare & Life Sciences and is based in Tel Aviv. Its latest recorded funding round was a Series B round in August 2026.
QuantHealth is a healthcare technology company that provides an AI-powered platform to simulate clinical trials in order to accelerate and de-risk drug development for pharmaceutical and biotechnology companies.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Drug Discovery, Healthcare Analytics, Synthetic Data, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Foundation
Historical Pricing
Historical view of private secondary pricing and transaction trends.
QuantHealth Comparables
Compare QuantHealth with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Unlearn | 85% | |
| PhaseV | 85% | |
| Intelligencia AI | 85% |
For institutional investors. Book with your work email.
QuantHealth Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 4, 2026 | ||||
| Strategic | Oct 2, 2025 | ||||
| Series A Extension | Jan 8, 2024 | ||||
| Series A | Aug 30, 2023 | ||||
| Seed | Oct 26, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
QuantHealth Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GC Ventures | Series B |
| Bertelsmann Investments | Series A |
| Bertelsmann Healthcare Investments | Series B |
| Nina Capital | Seed, Series A |
| Qumra Capital | Series B |
| Accenture Ventures | Series A, Series A Extension |
| Renegade Partners | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 84% MoM, reaching 6.3K.
- Aug 4, 2026
$45M round led by Qumra Capital.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingOct 7, 2026
QuantHealth Ltd. is developing virtual trial platforms that help drugmakers assess drug candidates and potentially reduce failed trials by simulating patient responses with genetic and real-world data.
For institutional investors. Book with your work email.
QuantHealth Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about QuantHealth's valuation, stock price, and market status.
Is QuantHealth a public or private company?
QuantHealth is a private company.
What is the current stock price of QuantHealth?
QuantHealth is a private company, so its shares have no public market price. Caplight tracks QuantHealth's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is QuantHealth worth (valuation)?
QuantHealth's valuation is estimated at $27.3M based on funding round data.
Can I buy QuantHealth stock?
QuantHealth shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was QuantHealth's last funding round?
QuantHealth's most recent funding round was Series B on August 4, 2026.
Who are the main investors in QuantHealth?
Key investors in QuantHealth include Bertelsmann Investments, Qumra Capital, Accenture Ventures, Sanofi Ventures, Pitango Venture Capital.
Will QuantHealth IPO soon?
No public IPO plans have been announced for QuantHealth.
How can I track QuantHealth secondary market activity?
Caplight tracks bids, offers, and trades in QuantHealth's shares on secondary markets.